Exploring the Impact of Dawn Phenomenon on Glucose-Guided Eating Thresholds in Individuals With Type 2 Diabetes Using Continuous Glucose Monitoring: Observational Study

被引:0
|
作者
Jospe, Michelle R. [1 ]
Marano, Kari M. [2 ]
Bedoya, Arianna R. [2 ]
Behrens, Nick L. [2 ]
Cigan, Lacey [2 ]
Villegas, Vanessa [2 ]
Magee, Michelle F. [3 ,4 ]
Marrero, David G. [2 ]
Richardson, Kelli M. [2 ]
Liao, Yue [5 ]
Schembre, Susan M. [1 ,6 ]
机构
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] Univ Arizona, Tucson, AZ USA
[3] MedStar Hlth Diabet & Res Inst, Washington, DC USA
[4] Georgetown Univ, Sch Med, Dept Med, Washington, DC USA
[5] Univ Texas Arlington, Arlington, TX USA
[6] Georgetown Univ, Lombardi Comprehens Canc Ctr, 800 Reservoir Rd NW, Washington, DC 20057 USA
关键词
self; -monitoring; food intake regulation; glycemic control; continuous glucose monitoring; glucose; appetite; diabetes; diabetic;
D O I
10.2196/46034
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Glucose-guided eating (GGE) improves metabolic markers of chronic disease risk, including insulin resistance, in adults without diabetes. GGE is a timed eating paradigm that relies on experiencing feelings of hunger and having a preprandial glucose level below a personalized threshold computed from 2 consecutive morning fasting glucose levels. The dawn phenomenon (DP), which results in elevated morning preprandial glucose levels, could cause typically derived GGE thresholds to be unacceptable or ineffective among people with type 2 diabetes (T2DM).Objective: The aim of this study is to quantify the incidence and day-to-day variability in the magnitude of DP and examine its effect on morning preprandial glucose levels as a preliminary test of the feasibility of GGE in adults with T2DM.Methods: Study participants wore a single-blinded Dexcom G6 Pro continuous glucose monitoring (CGM) system for up to 10 days. First and last eating times and any overnight eating were reported using daily surveys over the study duration. DP was expressed as a dichotomous variable at the day level (DP day vs non-DP day) and as a continuous variable reflecting the percent of days DP was experienced on a valid day. A valid day was defined as having no reported overnight eating (between midnight and 6 AM). partial differential Glucose was computed as the difference in nocturnal glucose nadir (between midnight and 6 AM) to morning preprandial glucose levels. partial differential Glucose & GE;20 mg/dL constituted a DP day. Using multilevel modeling, we examined the between -and within-person effects of DP on morning preprandial glucose and the effect of evening eating times on DP. Results: In total, 21 adults (59% female; 13/21, 62%) with non-insulin-treated T2DM wore a CGM for an average of 10.5 (SD 1.1) days. Twenty out of 21 participants (95%) experienced DP for at least 1 day, with an average of 51% of days (SD 27.2; range 0%-100%). The mean partial differential glucose was 23.7 (SD 13.2) mg/dL. People who experience DP more frequently had a morning preprandial glucose level that was 54.1 (95% CI 17.0-83.9; P<.001) mg/dL higher than those who experienced DP less frequently. For within-person effect, morning preprandial glucose levels were 12.1 (95% CI 6.3-17.8; P=.008) mg/dL higher on a DP day than on a non-DP day. The association between partial differential glucose and preprandial glucose levels was 0.50 (95% CI 0.37-0.60; P<.001). There was no effect of the last eating time on DP.Conclusions: DP was experienced by most study participants regardless of last eating times. The magnitude of the within-person effect of DP on morning preprandial glucose levels was meaningful in the context of GGE. Alternative approaches for determining acceptable and effective GGE thresholds for people with T2DM should be explored and evaluated.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring
    Barua, Souptik
    Glantz, Namino
    Larez, Arianna
    Bevier, Wendy
    Sabharwal, Ashutosh
    Kerr, David
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [2] Using Continuous Glucose Monitoring to Prescribe a Time to Exercise for Individuals with Type 2 Diabetes
    Chang, Courtney R.
    Russell, Brooke M.
    Cyriac, Tannia
    Francois, Monique E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [3] A continuous glucose monitoring in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGE, 2017, 13 (07): : 522 - 524
  • [4] Continuous glucose monitoring in type 2 diabetes
    Harman-Boehm, Ilana
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 : S118 - S121
  • [5] Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes Is this of concern?
    Monnier, Louis
    Colette, Claude
    Dejager, Sylvie
    Owens, David
    DIABETES CARE, 2013, 36 (12) : 4057 - 4062
  • [6] Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England
    Alsaif, Murtada
    Farhat, Ali
    Blumer, Zoe
    Barham, Leela
    HEALTH ECONOMICS REVIEW, 2024, 14 (01)
  • [7] Eating habits and sleep quality in individuals with type 1 diabetes on continuous glucose monitoring and insulin pump
    Corrado, Alessandra
    Scida, Giuseppe
    Vitale, Marilena
    Caprio, Benedetta
    Costabile, Giuseppina
    Annuzzi, Eric
    Della Pepa, Giuseppe
    Lupoli, Roberta
    Bozzetto, Lutgarda
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (07) : 1703 - 1711
  • [8] Continuous glucose monitoring in persons with type 2 diabetes not using insulin
    Cowart, Kevin
    Updike, Wendy H.
    Franks, Rachel
    EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (11) : 1049 - 1055
  • [9] Identifying improvements in exercise-induced glucose tolerance in individuals with Type 2 diabetes by continuous glucose monitoring
    Macdonald, AL
    Harrison, M
    Dickinson, H
    Bone, AJ
    Watt, PW
    DIABETOLOGIA, 2004, 47 : A248 - A248
  • [10] Improving glucose control in patients with type 2 diabetes using retrospective continuous glucose monitoring
    Diamond, Katlyn
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (07) : 425 - 433